The Enforcement Directorate and the Central Investigation Agency (CBI) have stepped up their efforts to nab the accused in the alleged bribery scam of Rs 3,600 crore in the AgustaWestland scam. A source familiar with the whole matter told this to Hindustan Times. ED raids on Wednesday at the premises of realty firm MGF MD Shravan Gupta were conducted to trace the same bribe money that went to several companies during a given period of time.

Read more at…

Bain Capital-backed Emcure Pharmaceuticals has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial share sale.The initial public offering IPO comprises fresh issuance of equity shares worth Rs 1,100 crore and an offer of sale of 18,168,356 shares by promoters and existing shareholders, according to the draft red herring prospectus DRHP.As a part of the OFS, promoters Satish Mehta and Sunil Mehta will offload 20.30 lakh and 2.5 lakh shares,…

Pune-based Emcure Pharmaceuticals is bullish about scientific innovation and its next big bet is mRNA vaccines for COVID-19, the company's Founder and MD Satish Mehta told YourStory.

“We are working on it (mRNA vaccines), and it will be absolutely comparable to the Pfizer and Moderna vaccines,” Emcure MD Satish Mehta told YourStory Founder Shradha Sharma in an interview.

Read More at…

The Centre on Tuesday informed that the country's first mRNA-based Covid vaccine was found to be safe, and was given go ahead for Phase II/III trials.

Gennova Biopharmaceuticals, the Pune-based biotechnology company, working on the nation's first mRNA-based Covid vaccine, submitted the interim clinical data of the Phase-I study to the Central Drugs Standard Control Organisation (CDSCO), the government's National Regulatory Authority (NRA).

Read more at…

In July 2020, the company had filed a complaint with the Gurugram Police Commissioner following which an investigation was carried out by the EOW and a case was registered at the DLF Phase-1 police station.

According to the FIR, Shravan Gupta is accused of causing a loss of about Rs 182.48 crore to the company through illegal land deals based on fake documents.

Emaar had stepped into the Indian real estate sector in 2005 through Foreign Direct Investment (FDI) and bought land…

New Delhi, Aug 19 (PTI) Bain Capital-backed Emcure Pharmaceuticals has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial share sale.

The initial public offering (IPO) comprises fresh issuance of equity shares worth Rs 1,100 crore and an offer of sale of 18,168,356 shares by promoters and existing shareholders, according to the draft red herring prospectus (DRHP).

As a part of the OFS, promoters Satish Mehta and Sunil Mehta will offload…

A Tis Hazari court on Friday summoned managing director of real estate major Emaar MGF Shravan Gupta as an accused after taking cognisance of the Income Tax department’s complaint against him for allegedly not furnishing details of his foreign bank accounts.

Additional Chief Metropolitan Magistrate Devendra Kumar Sharma has summoned Gupta on March 24.

Gupta’s name, along with others, has allegedly cropped up in the black money case.

Read More at…

Emcure Pharmaceuticals is aiming to be among the top five drug firms in the country in the next five to seven years as it also eyes acquisitions for growth going forward, a top company official said.The company is currently developing mRNA vaccine for COVID-19 through its subsidiary, Gennova Biopharmaceuticals.'We are now currently in the top 10 pharma companies in India and I would like to take the company to the top 5 in the next five to seven years for sure. That is one thing which is the…